Discover 2,717 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,717
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: St. John's, Boston MA, Norwich CT, New Haven CT, Quebec,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase3, Recruiting
To Assess Safety of Mitapivat and Provide Proof of Concept of the Efficacy of the Drug in Patients With RBC Membranopathies or CDAII.
for
Anemia
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT07055243
Phase2, Recruiting
Influence of Indoor Humidity on Physiological Strain in Older Adults During a Simulated Heat Wave
for
Heat Stress, Physiological Stress
Location: Ottawa
Sponsor: University of Ottawa
Sex: All
Age: 60 - 70+
Code: NCT06842953
Recruiting
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
for
Gastrointestinal Neoplasms
Location: Calgary, Sherbrooke, New York NY, Toronto, Montreal,
Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1,
Location: New York NY, Hershey PA, Ottawa, Wheaton MD,
Sponsor: ADARx Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06960213
Phase3, Recruiting
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Abington PA, Willow Grove PA, Miami FL,
Sponsor: Centessa Pharmaceuticals (UK) Limited
Sex: All
Age: 18 - 65
Code: NCT07096674
Phase2, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Squamous Non-Small Cell Lung Cancer
Location: Ottawa, Fairfax VA, Orange City FL, Houston TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07005102
Phase2, Phase3, Recruiting
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
for
Facioscapulohumeral Muscular Dystrophy, FSHD,
Location: Montreal, Ottawa, Edmonton, Calgary
Sponsor: Avidity Biosciences, Inc.
Sex: All
Age: 16 - 70
Code: NCT07038200
Phase3, Recruiting
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
for
Neoplasms, Lung
Location: Montreal, Ottawa, Wilson NC, Toronto, Los Angeles CA
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07099898
Phase3, Recruiting
Motivated to Move: A Study to Determine the Feasibility of Self-Monitoring Physical Activity in Youth